-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Clearside Biomedical, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2019 to 2023.
- Clearside Biomedical, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 74.7M shares, a 21.2% increase year-over-year.
- Clearside Biomedical, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 61.8M shares, a 2.66% increase from 2022.
- Clearside Biomedical, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 60.2M shares, a 0.5% increase from 2021.
- Clearside Biomedical, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 59.9M shares, a 28.8% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)